Recombinant exendin 4 (Yangtze River Pharmaceutical)
重组Exendin-4（扬子江药业）
Report date: 2022/03/21 20:00:32
Base Information
Drug NameRecombinant exendin 4 (Yangtze River Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesYangtze River Pharmaceutical (Group) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesYangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A